Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
7.29
+0.54 (8.00%)
Aug 13, 2025, 4:00 PM - Market closed
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $11.65 million as of August 13, 2025. Its market cap has decreased by -41.91% in one year.
Market Cap
11.65M
Enterprise Value
14.35M
1-Year Change
-41.91%
Ranking
Category
Stock Price
$7.29
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $11.65M, a decrease of -94.94%. That is a compound annual growth rate of -43.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 11.65M | -13.75% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | 147.37M | -35.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |